"Neutropenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A decrease in the number of NEUTROPHILS found in the blood.
Descriptor ID |
D009503
|
MeSH Number(s) |
C15.378.553.546.184.564
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neutropenia".
Below are MeSH descriptors whose meaning is more specific than "Neutropenia".
This graph shows the total number of publications written about "Neutropenia" by people in this website by year, and whether "Neutropenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 6 | 10 |
1995 | 5 | 4 | 9 |
1996 | 9 | 5 | 14 |
1997 | 3 | 11 | 14 |
1998 | 4 | 8 | 12 |
1999 | 4 | 10 | 14 |
2000 | 4 | 7 | 11 |
2001 | 4 | 3 | 7 |
2002 | 4 | 13 | 17 |
2003 | 8 | 8 | 16 |
2004 | 4 | 17 | 21 |
2005 | 6 | 9 | 15 |
2006 | 6 | 17 | 23 |
2007 | 2 | 10 | 12 |
2008 | 9 | 10 | 19 |
2009 | 10 | 13 | 23 |
2010 | 3 | 14 | 17 |
2011 | 9 | 11 | 20 |
2012 | 3 | 11 | 14 |
2013 | 2 | 13 | 15 |
2014 | 5 | 9 | 14 |
2015 | 5 | 10 | 15 |
2016 | 2 | 4 | 6 |
2017 | 5 | 16 | 21 |
2018 | 6 | 6 | 12 |
2019 | 5 | 10 | 15 |
2020 | 2 | 7 | 9 |
2021 | 8 | 5 | 13 |
2022 | 5 | 1 | 6 |
2023 | 13 | 2 | 15 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neutropenia" by people in Profiles.
-
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. Am J Hematol. 2024 Apr; 99(4):615-624.
-
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. J Antimicrob Chemother. 2024 Feb 01; 79(2):297-306.
-
A case of filgrastim-induced neutrophilic dermatosis of the dorsal hands in a patient with Felty Syndrome. Dermatol Online J. 2023 Dec 15; 29(6).
-
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro Oncol. 2023 12 08; 25(12):2262-2272.
-
Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma. JAMA Ophthalmol. 2023 Dec 01; 141(12):1133-1138.
-
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma. N Engl J Med. 2023 Sep 14; 389(11):1009-1022.
-
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study. Invest New Drugs. 2023 10; 41(5):677-687.
-
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel. Blood Cancer J. 2023 08 01; 13(1):116.
-
Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours. Eur J Cancer. 2023 10; 192:113259.
-
Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients. Am J Transplant. 2023 Dec; 23(12):1961-1971.